Pregnolia

Pregnolia

Ensuring every woman enjoys a happy, healthy, and well-informed pregnancy journey by advancing preterm birth risk assessment and birth management tools.

Founded 2016 2-10 employees Total: $9.85M Medical Devices

Pregnolia is a medical devices startup founded in 2016, with the mission of advancing preterm birth risk assessment and birth management tools. The company's dedication to ensuring a healthy and well-informed pregnancy journey for every woman is underlined by its commitment to developing a commercial version of their device, completing clinical trials, adhering to regulatory paths, and executing their business vision. The team at Pregnolia recognizes the potential of existing research on preterm birth assessment and is keen on bridging the gap in the market with their innovative solutions. The latest milestone for the company was the Fr.2.20M funding round investment at 16 November 2023, marking a significant step towards their goal. The absence of specific information about the investors in this particular round necessitates further inquiry. Overall, Pregnolia presents a promising venture in the medical devices sector, aiming to provide valuable tools for gynecologists to assess preterm birth risks and manage births more effectively. The company's focus on enhancing pregnancy experiences and addressing a critical aspect of women's health makes it an intriguing prospect for potential investors.

Funding Stage	Amount	Investors	Lead Investors	Date
Funding Round	Fr.2.20M	-		16 Nov 2023
Corporate Round	Undisclosed	1	Sanitas Health Insurance	04 May 2021
Series A	Fr.4.20M	4	Redstone, Verve Ventures +2	25 Jun 2020
Grant	Fr.20.00K	1	Venture Kick	09 Dec 2019
Grant	€71.43K	1	EASME - EU Executive Agency for SMEs	01 Jan 2019
Seed Round	Fr.3.25M	4	3wVentures, Verve Ventures +2	14 Feb 2018
Pre Seed Round	Fr.100.00K	1	Venture Kick	29 Jun 2016
Grant	Fr.10.00K	1	Venture Kick	11 Aug 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Funding Round

Fr.2.20M

16 Nov 2023

Corporate Round

Undisclosed

Sanitas Health Insurance

04 May 2021

Series A

Fr.4.20M

Redstone, Verve Ventures +2

25 Jun 2020

Grant

Fr.20.00K

Venture Kick

09 Dec 2019

Grant

€71.43K

EASME - EU Executive Agency for SMEs

01 Jan 2019

Seed Round

Fr.3.25M

3wVentures, Verve Ventures +2

14 Feb 2018

Pre Seed Round

Fr.100.00K

Venture Kick

29 Jun 2016

Grant

Fr.10.00K

Venture Kick

11 Aug 2015

FAQ About Pregnolia

Ensuring every woman enjoys a happy, healthy, and well-informed pregnancy journey by advancing preterm birth risk assessment and birth management tools.

Pregnolia was founded in 2016.

Pregnolia operates in Medical Devices. Its work centres on maternal health, pregnancy, preterm birth and women's health.

Pregnolia has approximately 2-10 employees.

Pregnolia has completed 8 funding rounds, raising a total of $9.85M.

Top alternatives and competitors to Pregnolia include Sera Prognostics, Bloomlife Inc, Shiphrah Biomedical Inc., Materna Medical, Baymatob. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Pregnolia and Sera Prognostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Pregnolia

Funding Rounds & Investors (8)

Pregnolia Alternatives & Competitors

FAQ About Pregnolia